This study assessed how many pediatric patients presenting for surgery at three tertiary care children's hospitals across the US had COVID-19.
In a new study, researchers at Children's Hospital of Philadelphia (CHOP) have performed the most comprehensive characterization of elementary school-age concussions to date, revealing an opportunity to improve outcomes for this age group through more consistent visio-vestibular assessments at the initial health care visit.
A distinguished panel of medical experts, state and federal health officials, and congenital heart disease parent advocates published recommended updates to the current American Academy of Pediatrics' protocol for detecting critical congenital heart disease (CCHD) in newborn babies using pulse oximetry. The recommendations appear in the June 2020 issue of Pediatrics.
Results of the phase III Inter-B-NHL-ritux 2010 clinical trial reported today in the New England Journal of Medicine show 95 percent three-year survival for pediatric patients with advanced B-cell non-Hodgkin lymphoma treated with the addition of anti-cancer immunotherapy rituximab to standard chemotherapy.
New research from UAlberta microbiologists has shed light on how the respiratory syncytial virus (RSV)--one of the most common viral infections--breaks into our cells to cause infection. In a study published in the journal Nature, associate professor of medical microbiology and immunology David Marchant and an international team of researchers discovered that RSV tricks cells into letting it in by essentially ringing a doorbell that calls its receptor to the virus waiting at the door.
The excellent results of the phase III international paediatric study, Inter-B-NHL ritux 2010, have been published in the New England Journal of Medicine. It establishes a new standard treatment with an improved cure rate for children with advanced non-Hodgkin lymphoma, mainly Burkitt lymphoma. It supports the value of an immunotherapeutic agent, which was authorised in March 2020 by the European Commission for the treatment of a rare childhood cancer.
Epidemiology, clinical and laboratory features of 50 children hospitalized with COVID-19 in New York are examined in this case series.
University of Queensland researchers have discovered why only 34 per cent of mothers exclusively breastfeed to six months, despite the global push to increase rates to 50 per cent.
The immunologic features of mild and moderate COVID-19 in pediatric patients is described and compared in this case series.
Children with severe hemophilia A who receive early prophylaxis are less likely to have joint damage in young adulthood than those who begin treatment later, according to a new study in Blood Advances. While data suggest earlier initiation of prophylaxis provides some protection compared to later initiation of prophylaxis, prophylaxis does not fully prevent joint damage.